Eye drop users everywhere have had it happen. Tilt your head back, drip a drop in your eye, and part of that drop always seems to dribble down your cheek. But what most people see as an annoyance, some prescription drop users say is grounds for a lawsuit

Quick Read

Rachel Ralph works long hours at an accounting firm in Oakland, Calif., and coordinates much of her life via the apps on her phone. So when she first heard several months ago that she could order her usual brand of birth control pills via an app and have them delivered to her doorstep in a day or two, it seemed perfect. She was working 12-hour days

Quick Read

At first glance, a bill passed by the House of Representatives this week seems like the kind of thing anyone could get behind. It would allow terminally ill patients access to experimental drugs without the approval of the FDA. But the bill and a similar one passed last summer by the Senate do little to address the main barrier that patients face in getting unapproved treatments: permission from the drug companies themselves

Quick Read

When an assessor arrived in 2016 and went over her situation, it was a familiar process: how much help did she need to use the bathroom? What about eating? How was her emotional state? The woman typed notes into a computer and, when it was over, gave Dobbs a shocking verdict: her hours would be cut, to just 32 per week

Quick Read

Opponents say the bill undermines the Food and Drug Administration’s existing compassionate use program while giving false hope to dying patients

Quick Read

US prosecutors said numerous Novartis AG sales representatives will testify they plied doctors with lavish meals, booze and other benefits in exchange for promises to prescribe the Swiss company’s drugs, as a seven-year-old case moves toward trial

Quick Read

Hospitals in Maryland have saved millions of dollars in health care costs by eschewing the tradition fee-for-service model for one that emphasizes overall health, a report released by state regulators shows

Quick Read

This spring, the National Institutes of Health will start recruiting participants for one of the most ambitious medical projects ever envisioned. The goal is to find one million people in the United States, from all walks of life and all racial and ethnic groups, who are willing to have their genomes sequenced, and to provide their medical records and regular blood samples

Quick Read